neuland-laboratories-ltd
Home
Neuland Laboratories Ltd
NEULANDLAB Share Price
BSE:
NSE:NEULANDLAB
NEULANDLAB Share Price
BSE:
NSE:NEULANDLAB
Pharmaceuticals
Mid Cap
₹-
0 (0%)
Market Cap
₹19,647.44 Cr
PE Ratio
74.39
Neuland Laboratories Ltd Performance
▲
▲
▲
▲
Neuland Laboratories Ltd Fundamentals
Neuland Laboratories Ltd Delivery and Volume
About Neuland Laboratories Ltd
Incorporated on January 7, 1984, Neuland Laboratories Limited (NLL) is promoted by Davuluri Sucheth Rao. The Company is engaged in manufacturing and selling of bulk drugs such as salbutamol sulphate, terbutaline sulphate, labetalol hydrochloride and ciprofloxacin. Neuland Drugs & Pharmaceuticals P
| Name | Designation |
|---|---|
| D R Rao | Executive Chairman |
| Christopher M Cimarusti | Non Executive Director |
| D Sucheth Rao | Vice Chairman & CEO |
| D Saharsh Rao | Vice Chairman & M.D. |
| Sarada Bhamidipati | Company Sec. & Compli. Officer |
| Nirmala Murthy | Independent Director |
| Homi Rustam Khusrokhan | Independent Director |
| Prasad R Menon | Independent Director |
| Sugata Sircar | Independent Director |
| Pallavi Joshi Bakhru | Independent Director |
News and Events...
Top Gainers Today
View All
Top Losers Today
View All
Neuland Laboratories Ltd FAQs
How do I Buy Neuland Laboratories Ltd Shares?
By opening a demat account and having your KYC papers confirmed online, you may simply purchase Neuland Laboratories Ltd shares in BlinkX.
What is the Share Price of Neuland Laboratories Ltd?
The share price of any stock is volatile and changes during the day due to a variety of variables. Neuland Laboratories Ltd's share price is ₹15265 as of 2024-12-15.
What is the PE ratio of Neuland Laboratories Ltd?
Neuland Laboratories Ltd's P/E ratio is 74.39 times as of 2024-12-15.
What is the PB ratio of Neuland Laboratories Ltd?
Neuland Laboratories Ltd's most recent financial reports indicate a price-to-book ratio of 14.09, showing the company's stock market valuation in relation to the value of its real assets.
What is the Market Cap of Neuland Laboratories Ltd?
Market capitalization, often known as market cap, is the market value of all outstanding shares of a publicly listed corporation. Neuland Laboratories Ltd's market capitalization is ₹19647.44 Cr as on 2024-12-15.
What is the ROE of Neuland Laboratories Ltd?
The current financial records of Neuland Laboratories Ltd show a 26.48% ROE, showing great financial performance and effective capital utilisation, making it a significant statistic for investors.
What is the Total Asset of Neuland Laboratories Ltd?
According to Neuland Laboratories Ltd's most recent financial filings, the company has a total asset value of ₹932.18, which includes current and non-current assets such as inventory, cash, properties, and equipment.
What is the 52-week high and Low of Neuland Laboratories Ltd?
The 52-week high/low price of a Neuland Laboratories Ltd stock is the highest and lowest price at which it has traded over that period (about one year) and is used as a technical indicator. Neuland Laboratories Ltd's 52-week high and low as of 2024-12-15 are ₹16076.8 and ₹15125, respectively.
